Related Experiment Video
Updated: Sep 2, 2025
07:23
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
6.2K
Platelets in Myocardial Ischemia/Reperfusion Injury
Nancy Schanze1,2, Muataz Ali Hamad1,3,4, Thomas Georg Nührenberg5,6
1Department of Cardiology and Angiology I, Heart Center, University of Freiburg, Freiburg, Germany.
Hamostaseologie
|August 1, 2022
Summary
Platelets significantly worsen cardiac damage after reperfusion therapy for myocardial infarction (MI). Understanding platelet roles in ischemia/reperfusion injury (IRI) is crucial for developing new treatments to protect the heart.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Pathophysiology
Background:
- Coronary artery disease and myocardial infarction (MI) are leading global causes of death.
- Reperfusion therapy improves outcomes but causes significant cardiac damage via ischemia/reperfusion injury (IRI).
- Platelets, beyond their role in atherosclerosis, are key mediators in myocardial IRI.
Approach:
- This review summarizes platelet properties influencing IRI.
- It details how platelet activation, aggregation, and release of substances contribute to IRI.
- The review also examines the impact of antiplatelet agents on IRI.
Key Points:
- Platelet activation by endothelial damage during IRI leads to microthrombi formation.
- Activated platelets release vasoconstrictors and enhance leukocyte infiltration.
- Platelet-leukocyte complexes exacerbate tissue damage in post-ischemic myocardium.
Conclusions:
- A deeper understanding of platelet involvement in myocardial IRI is essential.
- Targeting platelet activity offers a promising therapeutic strategy to mitigate IRI.
- Antiplatelet agents may provide benefits in IRI beyond their established antithrombotic effects.
Related Concept Videos
01:22Formation of the Platelet Plug
7.0K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.0K
01:18Structure and Function of Platelets
1.5K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.5K
01:16Clot Retraction and Fibrinolysis
6.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.8K
01:05Introduction to Hemostasis
8.8K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.8K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
624
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
624
01:21Myocarditis I: Introduction
25
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
25